0001062993-22-019372.txt : 20220908 0001062993-22-019372.hdr.sgml : 20220908 20220908165533 ACCESSION NUMBER: 0001062993-22-019372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220906 FILED AS OF DATE: 20220908 DATE AS OF CHANGE: 20220908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Prime Movers Lab Fund I LP CENTRAL INDEX KEY: 0001751631 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 221234334 BUSINESS ADDRESS: STREET 1: P.O. BOX 12829 CITY: JACKSON STATE: WY ZIP: 83002 BUSINESS PHONE: 3072035036 MAIL ADDRESS: STREET 1: P.O. BOX 12829 CITY: JACKSON STATE: WY ZIP: 83002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sloss Dakin CENTRAL INDEX KEY: 0001875411 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41058 FILM NUMBER: 221234333 MAIL ADDRESS: STREET 1: 126 E 56TH ST, 30TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxxinity, Inc. CENTRAL INDEX KEY: 0001851657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 862083865 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (254) 244-5739 MAIL ADDRESS: STREET 1: 1717 MAIN STREET STREET 2: SUITE 3388 CITY: DALLAS STATE: TX ZIP: 75201 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-09-06 0001851657 Vaxxinity, Inc. VAXX 0001751631 Prime Movers Lab Fund I LP P.O. BOX 12829 JACKSON WY 83002 0 0 1 0 0001875411 Sloss Dakin C/O PRIME MOVERS LAB FUND I LP P.O. BOX 12829 JACKSON WY 83002 0 0 1 0 Class A Common Stock 2022-09-06 4 S 0 5947 2.4029 D 2226965 I Held by COVAXX PML SPV 1 LP Class A Common Stock 2022-09-06 4 S 0 2234 2.4029 D 836499 I Held by COVAXX PML SPV 2 LP Class A Common Stock 2022-09-06 4 S 0 3934 2.4029 D 1473100 I Held by COVAXX PML SPV 3 LP Class A Common Stock 2022-09-06 4 S 0 25243 2.4029 D 9451674 D Class A Common Stock 3615038 I Held by Prime Movers Growth Fund 1 LP Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. Held by PML. PML GP I is the general partner of PML. Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. The price of $2.4029 per share represents a weighted average of purchase prices ranging from $2.40 to $2.42 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Prime Movers Lab Fund I LP /s/ Taylor Frankel, Authorized Person 2022-09-08 Dakin Sloss /s/ Taylor Frankel, Attorney-in-fact 2022-09-08